Market Cap

Oncimmune Holdings plc Market Capitalization:

£14.1 Million

GBP as of Jan. 1, 2025

US$17.8 Million

business Oncimmune Holdings plc Company Profile

Oncimmune Holdings plc Main Stock Listing

LSE: ONC

Market Capitalization History of Oncimmune Holdings plc

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Oncimmune Holdings plc market cap

Date Market Cap YoY Change
Jan. 1, 2025 £14.1 M -28.01%
Jan. 1, 2024 £19.7 M -59.58%
Jan. 1, 2023 £48.6 M -60.45%
Jan. 1, 2022 £122.9 M -4.56%
Jan. 1, 2021 £128.8 M 363.38%
Jan. 1, 2020 £27.8 M -62.63%
Jan. 1, 2019 £74.4 M -30.15%
Jan. 1, 2018 £106.5 M 5.02%
Jan. 1, 2017 £101.4 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Oncimmune Holdings plc Categories

United Kingdom languages Healthcare languages Biotechnology
United Kingdom Healthcare United Kingdom Biotechnology

Stocks & Indices

Oncimmune Holdings plc has the following listings and related stock indices.


Stock: LSE: ONC

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.